- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02585544
Ambulatory Prolapse Surgery (PROLAMBU)
Ambulatory Prolapse Surgery: Feasibility Study
Day surgery is performed in the same way as in full hospital admission, allowing same-day discharge without increased risk. It provides many grounds for patient satisfaction. Progress in surgical and anesthesia techniques now allows this form of management to be developed and prioritized.
Day-care surgery for prolapse has been little studied. The present study is intended to help extend its future implementation, the primary objective being to assess the feasibility of the day-care approach in prolapse surgery. The secondary objectives are to study criteria of non-eligibility for day-care prolapse surgery, reasons for patients' refusal, causes of failure, predictive factors for failure, patient satisfaction, postoperative complications, 2-year anatomic and functional results, pain, quality of life and sexuality, and postoperative onset of dyspareunia and urinary incontinence.
The design is for a prospective non-randomized study conducted in 3 gynecologic surgery sites managed by the Lyon hospitals board (Hospices Civils de Lyon).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France, 69500
- Hôpital Femme Mère Enfant
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Stage III or IV anterior genital prolapse (cystocele) on the Pelvic Organ Prolapse Quantification (POP-Q) classification and/or vaginal floor prolapse
- Vaginal approach with prosthetic reinforcement planned
- Patient eligible for day-surgery
- Patient consenting to participate
- Informed and signed consent
Exclusion Criteria:
- Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, progressive disease, etc.
- Patient with ≥1 ineligibility criterion for day-surgery
- Impaired lower-limb range of motion preventing positioning for surgery
- Pregnancy, ongoing or planned during the study period
- Progressive or latent infection or signs of tissue necrosis on clinical examination
- Non-controlled diabetes (glycated hemoglobin >8%)
- Treatment impacting immune response (immunomodulators), ongoing or within previous month
- History of pelvic region radiation therapy, at any time
- History of pelvic cancer
- Non-controlled progressive spinal pathology
- Known hypersensitivity to one of the implant components (polypropylene)
- Inability to understand information provided
- Not covered by a national health insurance scheme, prisoner or under administrative supervision.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Genital prolapse
Single arm: i.e., all patients
|
day-care surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patient with success for ambulatory surgery
Time Frame: Day 1 (postoperative)
|
Number of prolapse surgery patients actually managed on a day-care basis
|
Day 1 (postoperative)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
causes of non-eligibility for day-care management analysis
Time Frame: Day 1 (before surgery)
|
list and percentage
|
Day 1 (before surgery)
|
|
reasons for patients' refusal analysis
Time Frame: Day 1 (before surgery)
|
list and percentage
|
Day 1 (before surgery)
|
|
causes of failure of day-surgery analysis
Time Frame: Day 1 (postoperative)
|
list and percentage
|
Day 1 (postoperative)
|
|
Number of patients satisfied with day-surgery
Time Frame: Day 1 (postoperative)
|
Day 1 (postoperative)
|
|
|
Post-surgery complications
Time Frame: Day 1 (postoperative), month 1, year 1 and year 2
|
number and percentage of cases of infection, hematoma, urinary retention, healing defect (exposure or erosion), retraction, death
|
Day 1 (postoperative), month 1, year 1 and year 2
|
|
Number of prolapse correction failure
Time Frame: month 1, year 1 and year 2
|
month 1, year 1 and year 2
|
|
|
pain score analysis
Time Frame: month 1, year 1 and year 2
|
0 to 10 scale
|
month 1, year 1 and year 2
|
|
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
|
SF- 12 Short Form (12) Health Survey PFDI-20 : Pelvic Floor Distress Inventory PFIQ-7 : Pelvic Floor Impact Questionnaire PGI-I : Patient Global Impression of Improvement
|
month 1, year 1 and year 2
|
|
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
|
SF- 12 Short Form (12) Health Survey
|
month 1, year 1 and year 2
|
|
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
|
PFDI-20 : Pelvic Floor Distress Inventory
|
month 1, year 1 and year 2
|
|
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
|
PGI-I : Patient Global Impression of Improvement
|
month 1, year 1 and year 2
|
|
quality of life scores analysis
Time Frame: month 1, year 1 and year 2
|
PFIQ-7 : Pelvic Floor Impact Questionnaire
|
month 1, year 1 and year 2
|
|
sexuality score analysis
Time Frame: month 1, year 1 and year 2
|
PISQ-12 questionnaire
|
month 1, year 1 and year 2
|
|
percentage dyspareunia
Time Frame: month 1, year 1 and year 2
|
month 1, year 1 and year 2
|
|
|
number of onset of urinary incontinence
Time Frame: month 1, year 1 and year 2
|
month 1, year 1 and year 2
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL15_0215
- 2015-A00599-40 (Other Identifier: ID-RCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genital Prolapse
-
Fundació Institut de Recerca de l'Hospital de la...Carlos III Health Institute; Ministry of Science and Innovation, SpainCompletedProlapse; Female | Prolapse Genital | Prolapse UterovaginalSpain
-
Hospital Mutua de TerrassaGermans Trias i Pujol Hospital; Hospital Arnau de Vilanova; Fundació Institut...RecruitingProlapse; Female | Prolapse Genital | Prolapse UterovaginalSpain
-
Kocaeli UniversityRecruitingGenital ProlapseTurkey (Türkiye)
-
Rennes University HospitalCompleted
-
University of South FloridaCompletedProlapse GenitalUnited States
-
Melissa Fischer, MDWilliam Beaumont HospitalsTerminated
-
Karolinska InstitutetCompleted
-
Ramsay Générale de SantéRecruiting
-
Assiut UniversityNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesTerminated
Clinical Trials on day-care surgery
-
Postgraduate Institute of Medical Education and...Completed
-
Oslo University HospitalCompleted
-
Region SkaneCompleted
-
West China HospitalRecruitingSurgery | Fast Recovery SurgeryChina
-
Clinton BahlerIndiana University; On Target Laboratories, LLCRecruitingProstate Cancer Metastatic Disease | Prostate Cancer SurgeryUnited States
-
First Hospital of China Medical UniversityRecruitingColorectal Carcinoma | Day SurgeryChina
-
Lei LiUnknownDeep Venous Thrombosis | Gynecologic Neoplasm | Ankle Motion | Abdominal BreathingChina
-
UMC UtrechtRadboud University Medical CenterRecruitingSpinal MetastasesNetherlands
-
EngenderHealthUnited States Agency for International Development (USAID); World Health OrganizationCompletedVaginal FistulaKenya, Ethiopia, Congo, The Democratic Republic of the, Guinea, Nigeria, Niger, Sierra Leone, Uganda
-
Helsinki University Central HospitalCompletedHernia, InguinalFinland